AI Chat Paper
Note: Please note that the following content is generated by AMiner AI. SciOpen does not take any responsibility related to this content.
{{lang === 'zh_CN' ? '文章概述' : 'Summary'}}
{{lang === 'en_US' ? '中' : 'Eng'}}
Chat more with AI
PDF (681.8 KB)
Collect
Submit Manuscript AI Chat Paper
Show Outline
Outline
Show full outline
Hide outline
Outline
Show full outline
Hide outline
Review | Open Access

Current status of traditional Chinese medicine in modulating mitochondrial metabolic abnormalities in tumors

Siyi Ma1,2Jiarong Li1,2Bingjie Hao1 ( )Lihong Fan1,3 ( )
Institute of Energy Metabolism and Health, Shanghai Tenth People’s Hospital Tongji University School of Medicine, Shanghai 200072, China
China Pharmaceutical University, Nanjing 210009, China
Department of Respiratory Medicine, Shanghai Sixth People’s Hospital, Shanghai 200233, China
Show Author Information

Abstract

Tumor cells undergo metabolic reprogramming to adapt to rapid proliferation and harsh microenvironments, as evidenced by aerobic glycolysis. Mitochondria serve as key coordinators of this process. Under internal and environmental stress in tumors, mitochondria reprogram metabolism by balancing energy dynamics, redirecting metabolic routes, communicating via metabolites, and preserving the quality of mitochondria, thus supporting tumor cell survival. Traditional Chinese medicine (TCM) has a key role in modulating mitochondrial reprogramming in tumor cells, possibly disrupting metabolic pathways that are necessary for survival and proliferation. However, the underlying molecular signaling and cellular biological mechanisms need to be elucidated. In this review, we focused on the Key functions of mitochondria in adapting to tumor metabolic reprogramming are the focus of this review and recent advances in and regulatory mechanisms of TCM and nano-pharmaceutical formulations in maintaining mitochondrial homeostasis are discussed. These insights may help understand the role of mitochondria in the pathogenesis of metabolic diseases, such as cancer, and identify therapeutic targets.

References

【1】
【1】
 
 
Cancer Biology & Medicine
Pages 1439-1454

{{item.num}}

Comments on this article

Go to comment

< Back to all reports

Review Status: {{reviewData.commendedNum}} Commended , {{reviewData.revisionRequiredNum}} Revision Required , {{reviewData.notCommendedNum}} Not Commended Under Peer Review

Review Comment

Close
Close
Cite this article:
Ma S, Li J, Hao B, et al. Current status of traditional Chinese medicine in modulating mitochondrial metabolic abnormalities in tumors. Cancer Biology & Medicine, 2025, 22(12): 1439-1454. https://doi.org/10.20892/j.issn.2095-3941.2025.0246

106

Views

2

Downloads

0

Crossref

1

Web of Science

0

Scopus

Received: 08 May 2025
Accepted: 13 August 2025
Published: 23 September 2025
©2025 The Authors.

Creative Commons Attribution-NonCommercial 4.0 International License